INHALED NITRIC OXIDE MARKET Size and trends

Inhaled Nitric Oxide Market, By Product Type (Inhaled Nitric Oxide Delivery Systems, Consumables, (Nitric Oxide Cylinders and Delivery Accessories), and Others), By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), acute respiratory distress syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment, and Others), By Strength (100 ppm, 800 ppm, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Home Care Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI7478
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Inhaled Nitric Oxide Market Size and Trends

The Inhaled Nitric Oxide Market is estimated to be valued at USD 1.31 Bn in 2025 and is expected to reach USD 2.21 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Inhaled Nitric Oxide Market Key Factors

To learn more about this report, Request sample copy

The non-invasive nature of inhaled nitric oxide and its selective vasodilating property helps in improving oxygenation in newborn babies suffering from hypoxic respiratory failure. This makes inhaled nitric oxide an attractive therapeutic option over other conventional vasodilators. Furthermore, rising incidences of pre-term births worldwide has significantly contributed to the rising cases of neonatal pulmonary hypertension, thereby increasing the demand for inhaled nitric oxide. Growing awareness regarding the benefits of inhaled nitric oxide and strong clinical evidence supporting its efficacy are further expected to support the market growth during the forecast period.

INHALED NITRIC OXIDE MARKET Size and trends

Inhaled Nitric Oxide Market Size and Trends

Inhaled Nitric Oxide Market Report Snapshots

EXISTING CLIENTELE